Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director 2019-11-11 19:30
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Taiwan Healthcare Pavilion Promotes Their Smart Medical Industry in Phillipines 2019-11-11 15:31
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features 2019-11-11 13:28
Akeso, Inc. Completes Series-D Private Financing for US$150 Million 2019-11-09 00:43
Ortoma Initiates Expansion With Module for Spine Surgery 2019-11-08 21:40
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company 2019-11-08 21:24
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial 2019-11-08 21:00
SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe 2019-11-08 17:36
Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes 2019-11-08 11:00
Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent 2019-11-08 03:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 21:02
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million 2019-11-07 19:04
Bactiguard Holding AB (publ): Interim Report for Q3 2019 2019-11-07 15:23
MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS) 2019-11-07 14:43
FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays 2019-11-07 12:00
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-11-07 11:02
First Asia-Pacific hospital treats patients with RayStation and Radixact 2019-11-07 09:00
1 611 612 613 614 615 962